Notice of Correction to Eligibility Information in PAR-18-947 "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01)"

Notice Number: NOT-CA-19-042

Key Dates
Release Date: April 05, 2019

Related Announcements
PAR-18-947

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Eligibility information in PAR-18-947 "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01)".

Part 2. Full Text of Announcement, Section III. Eligibility Information, Eligible Applicants, Eligible Organizations

Currently reads:

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statementare not allowed.

Corrected to read (in italics):

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statementare allowed.

All other aspects of PAR 18-947 remain unchanged.

Inquiries

Please direct all inquiries to:

Lokesh Agrawal, Ph.D.
National Cancer Institute (NCI)
Telephone: (240) 276-5718
Email: Lokesh.agrawal@nih.gov

Abhi Rao, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5715
Email:abhi.rao@nih.gov